Home/Filings/4/0001470831-25-000332
4//SEC Filing

Whalen Amanda 4

Accession 0001470831-25-000332

CIK 0001835830other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:07 PM ET

Size

17.2 KB

Accession

0001470831-25-000332

Insider Transaction Report

Form 4
Period: 2025-11-14
Whalen Amanda
Chief Financial Officer
Transactions
  • Sale

    Series A Common Stock

    2025-11-14$27.89/sh300$8,367481,719 total
  • Conversion

    Series A Common Stock

    2025-11-15+29,513511,232 total
  • Conversion

    Series B Common Stock

    2025-11-1415,000378,476 total
    Series A Common Stock (15,000 underlying)
  • Sale

    Series A Common Stock

    2025-11-14$28.61/sh14,700$420,567482,019 total
  • Conversion

    Series A Common Stock

    2025-11-14+15,000496,719 total
  • Tax Payment

    Series A Common Stock

    2025-11-15$28.61/sh45,058$1,289,109466,174 total
  • Conversion

    Series B Common Stock

    2025-11-1529,513348,963 total
    Series A Common Stock (29,513 underlying)
Footnotes (8)
  • [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.
  • [F2]Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.96 to $28.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.805 to $27.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Represents 29,513 shares of Series B Common Stock automatically converted into shares of Series A Common Stock in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs").
  • [F6]Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs.
  • [F7]Consists of (i) 66,642 shares of Series A Common Stock and (ii) 399,532 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
  • [F8]Consists of (i) 239,588 shares of Series B Common Stock and (ii) 109,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.

Issuer

Klaviyo, Inc.

CIK 0001835830

Entity typeother

Related Parties

1
  • filerCIK 0001991131

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:07 PM ET
Size
17.2 KB